Shycocan – Virus Attenuation Device

The World’s first proven technology to bring things back to normal is here.

Botswana Guardian: Kindly introduce Insperon Technologies to our readers? Insperon Technology Managing Director,

Clement Michael: Insperon Technologies was established in 2020 and is 100percent citizen based company. It’s aim is to provide innovative products that are useful for consumers in Botswana.

Botswana Guardian: We understand the company has a new device which helps guard against Corona Virus, kindly introduce the product to us?

Clement Michael: Shycocan, World’s First Virus Attenuation Device launched In Botswana. Invented by well- known scientist, Dr. Rajah Vijay Kumar, the device aims to get life and businesses back to normal amidst the pandemic

• The device is proven to disable the Coronavirus and Influenza virus strains in indoor spaces, which carry the highest risk of transmission

• Shycocan is scientifically evidenced to attenuate/ neutralise 99.9percent of both airborne and surface- borne Coronavirus family and Influenza family of viruses

• Shycocan also works on all current and future

variants and mutants of these viruses

• A safe environment for both B2B and B2C

The Coronavirus family is a virus enclosed in a positive charged Spike- Protein capsid while the human cell membrane carries a negative charge. Due to this opposite charge, the SProtein on the Coronavirus is able to enter the human cells through the ACE2 receptors and uses its cellular mechanism like a photocopy machine to duplicate itself. Shycocan works by neutralizing its positive charge and disabling the ability of the Coronavirus particles to attach itself to a host cell. The core of this specialized device is made of a super- alloy that was built after a decade of research and produces Photons of high intensity when excited. Upon striking solid surfaces like particles in the air, virus particles, tables, chairs, walls, etc., in a space, these emit electrons. The electrons get attached to the positive protein on the shell of the coronavirus and influenza virus families, neutralizing its positive charge and preventing it from infecting other people. This process is called “Virus Attenuation”. The virus attenuation is effective, both for surface and air- borne Coronaviruses. In the presence of Shycocan, anyone touching a previously infected surface will not contract the virus, providing far greater protection and safety than any other technology. The super- alloy generating photons does not deteriorate, hence Shycocan has a long lifespan and requires minimal servicing and no consumables. The cylindrical device, Shycocan is scientifically evidenced to neutralise and help curb the spread of the Coronavirus and the Influenza family of viruses in indoor spaces with 99.9percent efficacy, enabling schools, colleges, homes and businesses like hospitals, hotels, offices, restaurants, auditoriums, transportation, retail, and airports get back to normal and serve the customers in a safe environment. Shycocan has been certified as European Union CE Class- I product, and Shycocan was sent to leading laboratories for testing and the results showed 99.9percent* efficacy in disabling the Coronavirus and Influenza Virus Family. It was also subjected to the full spectrum of tests for safety and the device unquestionably excelled in all of them. It already conforms to the regulatory requirements of US, Europe, Australia, New Zealand, Malaysia, UAE, South Africa, India, many other countries and is being made available worldwide. Distributed in the Botswana and other SADC countries by Insperon Technologies, Shycocan is thoroughly tested devices and it neither uses nor emits radiation, chemicals, ozone, any toxic material. It is 100percent safe for humans, animals, and the environment. Additionally, it does not harm the bacterial ecosystem and microbes that thrive in the environment and are essential for our immunity. Remarkably, Shycocan also works on all current and future variants and mutants of these viruses, protecting people’s health and saving millions of hours of lost productivity.

Botswana Guardian: What is the target market of the device?

Clement Michael: Shycocan has widespread usage across market segments, including hospitals, clinics, schools, higher education institutions, banking sector, manufacturing and retail outlets, hospitality sector, government offices, real estate corporations, restaurants and businesses. In addition to the solution, the company offers customised consultations, a one- year replacement warranty, strong support and service network across Botswana, and a post- installation audit.

Botswana Guardian: Has it been approved by health authorities in Botswana?

Clement Michael: Yes, this device has been assessed and exempted by BOMRA for emergency use under class 1 device. Further the device has been allowed for use in USA by FDA, USA under public health emergency conditions. TNO, Netherland tested the efficacy of the device for SARS- CoV- 2 virus with favourable results in April 2021.

Botswana Guardian: How much does to cost per unit?

Priced at P 8900-, a single device when mounted has an effective coverage area of 1,000 square feet ( 10,000 cubic feet). Multiple devices can be installed to cover a larger indoor space. The device has seen a robust demand from institutional buyers across the globe and is already in use in countries such as India, the US, Europe, Malaysia, Australia, New Zealand, South Africa, UAE, Qatar, Kuwait, Ghana, Kenya among others. Botswana Guardian: How has the device been received so far?

Clement Michael: Looking at the present covid situation, we have already secured orders of our first consignments, before we launch the device in Botswana. We are expecting the first stock to arrive by 10 July 2021. We are currently doing promotions in the local media and social media. Any one interested in the product can place orders at: sales@ insperontech. co. bw or call at 77304444.

ABOUT SHYCOCAN CORPORATION

Shycocan Corporation, is a global licensee of the device, for manufacturing, sales, marketing, distribution, and services. Shycocan is the world’s first Virus Attenuation Device that can disable the entire Coronavirus and Influenza families of viruses in indoor spaces with 99.9percent efficacy while being completely safe for humans, animals and the environment, as proven in multiple virology lab test reports. It conforms to the regulatory requirements of the US, Europe, Australia, New Zealand, Malaysia, UAE, South Africa, India and many other countries. Shycocan Corporation is founded by a team of blue- chip technology and industry professionals led by Mr. Alok Sharma, the former MD of Apple India. Dr. Rajah Vijay Kumar, is the scientistinventor behind the Shycocan device and holds over 30+ inventions globally. The company’s immediate goal is to ensure indoor environments are free of transmission risks from Coronavirus and Influenza virus families of the present and the future for organisations to restart their business and help bring life back to normal. The company backs up its offering with customised consultations, a one- year replacement warranty, a global support and service network and a post- installation audit. The target customer segments of the company include hospitals, clinics, schools, higher education, banking, manufacturing, retail, hospitality, entertainment, fitness, government offices, real estate, other businesses, and homes.